References
1. Francesco Cosentino, Peter J. Grant, Victor Aboyans, Clifford J. Bailey, Antonio Ceriello, Victoria Delgado et al. - 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD, European Heart Journal, 2020; 41: 255-323 DOI: 10/1093/eurheartj/ehz486
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140 2150
3. Kober Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjaer H, Brandes A, Thogersen AM, Gustafsson F, Egstrup K, Videbaek R, Hassager C, Svendsen JH, Hofsten DE, Torp-Pedersen C, Pehrson S; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221 1230
4. MacDonald MR, She L, Doenst T, Binkley PF, Rouleau JL, Tan RS, Lee KL, Miller AB, Sopko G, Szalewska D, Waclawiw MA, Dabrowski R, Castelvecchio S, Adlbrecht C, Michler RE, Oh JK, Velazquez EJ, Petrie MC. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Eur J Heart Fail 2015;17:725 734
5. Kilic A, Weiss ES, George TJ, Arnaoutakis GJ, Yuh DD, Shah AS, Conte JV. What predicts long-term survival after heart transplantation?
6. J. Spinarova, P. Lidinsky, P. Hude, J. Krejci, H. Poloczkova, J. Godava, J. Vitovec – Metabolic profile of patients after heart transplantation, Science Direct, 2013; 55: e324-e329 DOI: 10.1016/j.crvasa.2013.06.010
7. Ho Jin Kim, Sung-Ho Jung, Jae-Joong Kim, Tae-Jin Yun, Joon Bum Kim, Suk Jung Choo, Cheol Hyun Chung, Jae Won Lee – New-onset diabetes mellitus after heart transplantation, Circ J, 2017; 81: 806-814 DOI: 10.1253/circj.CJ-16-0963
8. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222.
9. Rawshani A, Sattar N, Franzen S, Rawshani A, Hattersley AT, Svensson AM, Eliasson B, Gudbjornsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018;392:477-486.
10. Sattar N, Rawshani A, Franzen S, Rawshani A, Svensson AM, Rosengren A, McGuire DK, Eliasson B, Gudbjornsdottir S. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation 2019;139:2228 2237
11. Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RF, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO - Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020 Mar 30:2047487320913379. doi: 10.1177/2047487320913379. Online ahead of print.
12. Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Liem AH, Rutten E, Hoes AW. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia 2012;55:2154-2162.
13. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004. Lancet
14. Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, Brueckmann M, Ofstad AP, Pfarr E, Jamal W, Packer M. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020 Sep 19;396(10254):819-829. doi: 10.1016/S0140-6736(20)31824-9. Epub 2020 Aug 30.
15. Kemps H, Kränkel N, Dörr M, Moholdt T, Wilhelm M, Paneni F, Serratosa L, Ekker Solberg E, Hansen D, Halle M, Guazzi M. Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2019 May;26(7):709-727. doi: 10.1177/2047487318820420. Epub 2019 Jan 14.
16. Kränkel N, Bahls M, Van Craenenbroeck EM, Adams V, Serratosa L, Solberg EE, Hansen D, Dörr M, Kemps H. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work? Eur J Prev Cardiol. 2019 May;26(7):701-708. doi: 10.1177/2047487318805158. Epub 2018 Oct 15
17. Syed Haris Ahmed, Kathryn Biddle, Titus Augustine, Shazli Azmi – Post-transplantation diabetes mellitus, Diabetes Ther, 2020; 11: 779-801 DOI: 10.1007/s13300-020-00790-5
18. Tahseen A. Chowdhury – Post-transplant diabetes mellitus, Clinical medicine, 2019; 19(5): 392-5
19. Ye X, Kuo HT, Sampaio MS, et al. Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients, Transplantation, 2010; 89:1526–1532, PubMed: 20431437
20. Bindu Chamarthi, Barak Zafrir, Jorge Plutzky, and Michael M. Givertz - Impact of pre-diabetes on heart transplant outcomes in patients with advanced heart failure, The Journal of Heart and Lung Transplantation, 2014 February; 33(2): 215–217. DOI:10.1016/j.healun.2013.10.018
21. M.R. Costanzo, A. Dipchand, R. Starling, et al. - The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients, Journal of Heart and Lung Transplantation, 2010; 29: 914–956
22. B. Depcynski, B. Daly, L.V. Cambell, et al., Predicting occurrence of diabetes mellitus in recipients of heart transplants, Diabetic Medicine 17 (2000) 15–19.
23. Katarzyna Zielinska, Leszek Kukulski, Marta Wrobel, Piotr Przybylowski, Michal Zakliczynski, Krzysztof Strojek - Prevalence and risk factors of new-onset diabetes after transplantation (NODAT), Annals of Transplantation, 2020; 25: e926556 DOI: 10.12659/AOT.926556
24. José A Moro, Luis Martínez-Dolz, Luis Almenar, Luis Martínez-Ortiz, Carlos Chamorro, Carlos García, Miguel A Arnau, Joaquín Rueda, Esther Zorio, Antonio Salvador - Impact of Diabetes Mellitus on Heart Transplant Recipients, Rev Esp Cardiology, 2006; 59(10):1033-7
25. S. Sehgal, M.J. Bock, H.L. Palac, J.G. Gossett, B.S. Marino, C.L. Backer, E. Pahl - New Onset Diabetes Mellitus After Heart Transplant in Children, The Journal of Heart and Lung Transplantation, 2015; 34 (4), S325
26. B. Reichart, B. Meiser, M. Gitano, et al., European Multicentre Tacrolimus (FK 506) Heart Pilot Study: one year results—European Tacrolimus Multicentre Heart Study Group, Journal of Heart and Lung Transplantation 17 (1998) 775–781
27. L. Nikolaidis, S. Shah, F. McGonagle, et al., Diabetes mellitus following heart transplantation, Journal of Heart and Lung Transplantation 29 (2010) S154
28. Joana Saraiva, Emilia Sola, David Prieto, Manuel J. Antunes – Diabetes as an outcome predictor after heart transplantation, Interactive Cardiovascular and Thoracic Surgery, 2011; 13: 499-504 DOI: 10.1510/icvts.2010.256321
29. Anisha Jagpal, Sudeep Das De, Sanjeet Singh Avtaar Singh, Alan Kirk - Is tacrolimus more likely to induce diabetes mellitus than ciclosporin in heart transplant patients? Vessel Plus, 2018; 2(24): 1-14 DOI: 10.20517/2574-1209.2018.27
30. Peled Y, Lavee J, Raichlin E, Katz M, Arad M, Kassif Y, Peled A, Asher E, Elian D, Har-Zahav Y, Shlomo N, Freimark D, Goldenberg I, Klempfner R. - Metformin therapy reduces the risk of malignancy after heart transplantation, J Heart Lung Transplant. 2017 Jun 23. pii: S1053-2498(17)31874-0. doi: 10.1016/j.healun.2017.06.009
31. Didsbury M, McGee RG, Tong A, Craig JC, Chapman JR, Chadban S, Wong G. Exercise training in solid organ transplant recipients: a systematic review and meta-analysis, Transplantation, 2013;95:679–687
32. Hsieh PL, Wu YT, Chao WJ. Effects of exercise training in heart transplant recipients: a meta-analysis. Cardiology. 2011;120:27–35;
33. Kari Nytrøen and Lars Gullestad - Exercise after heart transplantation: An overview, World J Transplant. 2013 Dec 24; 3(4): 78–90 DOI: 10.5500/wjt.v3.i4.78
Notes to editor
Author information:
Maria Simonenko, EAPC Secondary Prevention and Rehabilitation Section nucleus member,
Heart Transplantation Outpatient Department, Cardiopulmonary Exercise Test Research Department, Almazov National Medical Research Centre, St. Petersburg, Russia
Hareld Kemps, Department of Cardiology, Maxima Medical Centre, Veldhoven, The Netherlands; Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands
